|
1
|
Manuel RP, Tania GG, Rafael SP, Antonio PE, José BM, Asteria LÁ, Pablo CB, Alejandro LP, Pablo ÁN, Benjamín MB. In Vitro Development of a New Sponge-Based Delivery System for Intracanal Antimicrobial Administration in Endodontic Treatment. J Clin Med 2021; 10:jcm10122725. [PMID: 34205509 PMCID: PMC8233951 DOI: 10.3390/jcm10122725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Revised: 06/17/2021] [Accepted: 06/17/2021] [Indexed: 11/16/2022] Open
Abstract
This study aimed to evaluate the in vitro performance of collagen-based sponges as a drug delivery system for intracanal antimicrobial administration. Four groups of loaded collagen-based sponges (A, 0.3% w/v amoxicillin trihydrate: potassium clavulanate (4:1); B, 0.03% w/v chlorhexidine gluconate [CHX]; C, 0.3% w/v amoxicillin trihydrate: potassium clavulanate (4:1) and 0.03% w/v CHX; D, 1% w/v amoxicillin trihydrate: potassium clavulanate (4:1) and 0.03% w/v CHX) were designed. Release kinetics were tested in vitro on cultures in Petri dishes, and the effect on bacterial biofilms was studied ex vivo on 114 extracted human single-rooted teeth. Biofilm formation was tested by scanning electron microscopy (SEM). Collagen sponges containing amoxicillin and chlorhexidine showed a time-sustained antimicrobial effect in vitro and were also able to destroy mature biofilms ex vivo. This datum was validated by means of SEM-based study of E. faecalis and S. aureus biofilms.
Collapse
Affiliation(s)
- Ruíz-Piñón Manuel
- Faculty of Medicine and Odontology, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain; (R.-P.M.); (S.-P.R.); (P.-E.A.); (C.-B.P.); (L.-P.A.); (Á.-N.P.); (M.-B.B.)
| | - Gancedo-Gancedo Tania
- Faculty of Medicine and Odontology, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain; (R.-P.M.); (S.-P.R.); (P.-E.A.); (C.-B.P.); (L.-P.A.); (Á.-N.P.); (M.-B.B.)
- Correspondence:
| | - Seoane-Prado Rafael
- Faculty of Medicine and Odontology, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain; (R.-P.M.); (S.-P.R.); (P.-E.A.); (C.-B.P.); (L.-P.A.); (Á.-N.P.); (M.-B.B.)
| | - Pérez-Estévez Antonio
- Faculty of Medicine and Odontology, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain; (R.-P.M.); (S.-P.R.); (P.-E.A.); (C.-B.P.); (L.-P.A.); (Á.-N.P.); (M.-B.B.)
| | - Blanco-Méndez José
- Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain;
- Faculty of Sciences, University of Santiago de Compostela, 27002 Lugo, Spain;
- Paraquasil Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain
| | - Luzardo-Álvarez Asteria
- Faculty of Sciences, University of Santiago de Compostela, 27002 Lugo, Spain;
- Paraquasil Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain
| | - Castelo-Baz Pablo
- Faculty of Medicine and Odontology, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain; (R.-P.M.); (S.-P.R.); (P.-E.A.); (C.-B.P.); (L.-P.A.); (Á.-N.P.); (M.-B.B.)
| | - Lorenzo-Pouso Alejandro
- Faculty of Medicine and Odontology, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain; (R.-P.M.); (S.-P.R.); (P.-E.A.); (C.-B.P.); (L.-P.A.); (Á.-N.P.); (M.-B.B.)
| | - Álvarez-Novoa Pablo
- Faculty of Medicine and Odontology, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain; (R.-P.M.); (S.-P.R.); (P.-E.A.); (C.-B.P.); (L.-P.A.); (Á.-N.P.); (M.-B.B.)
| | - Martín-Biedma Benjamín
- Faculty of Medicine and Odontology, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain; (R.-P.M.); (S.-P.R.); (P.-E.A.); (C.-B.P.); (L.-P.A.); (Á.-N.P.); (M.-B.B.)
| |
Collapse
|
|
2
|
Sergio AP, Isabel DSFDRC, José BM, Otero-Espinar FJ. Fast and Controlled Release of Triamcinolone Acetonide from Extrusion-Spheronization Pellets Based on Mixtures of Native Starch with Dextrin or Waxy Maize Starch. Drug Dev Ind Pharm 2008; 33:945-51. [PMID: 17891580 DOI: 10.1080/03639040601128720] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Pellets composed chiefly of inexpensive starches allow modulation of the rate of release of the poorly soluble drug triamcinolone acetonide in media of pH 1.2-6.8. Wheat- or maize-starch-based pellets with 20% of white dextrin release the drug in vitro almost completely within 20 min, while maize-starch-based pellets with 5-35% of waxy maize starch sustain gradual release over periods of 9-12 hr or longer when prepared using appropriate amounts of granulation fluid.
Collapse
Affiliation(s)
- Almeida-Prieto Sergio
- Departamento de Farmacia y Tecnología Farmacéutica, Universidad de Santiago de Compostela, Santiago de Compostela, Spain
| | | | | | | |
Collapse
|